Literature DB >> 3407462

The value of continuous intra-operative EEG monitoring during carotid endarterectomy.

H A van Alphen1, C H Polman.   

Abstract

In a retrospective study, an evaluation was made of the intra-operative EEG findings and clinical results of 100 consecutive carotid endarterectomies carried out in 90 patients over the period 1977 to 1983. There was no operation-associated mortality; the peri-operative morbidity was 5%. All operations were performed maintaining the systemic blood pressure some 20% above the patients normal value. No interval shunt was used. The surgical policy was not influenced by EEG findings in any of the procedures. There was no relationship between carotid-clamping time and intra-operative EEG changes, nor was there a relationship between EEG changes and clinical outcome. It is most likely that neurological deficit following carotid endarterectomy, if operation is performed during elevated systemic blood pressure, is not due to haemodynamic disturbances, as a consequence of critical reduction of cerebral blood flow during internal carotid artery clamping, but to micro-embolism. From this assumption, it can be concluded that peri-operative complications of carotid endarterectomy cannot be reduced by intra-operative EEG monitoring.

Entities:  

Mesh:

Year:  1988        PMID: 3407462     DOI: 10.1007/bf01424561

Source DB:  PubMed          Journal:  Acta Neurochir (Wien)        ISSN: 0001-6268            Impact factor:   2.216


  19 in total

1.  Carotid endarterectomy. Complications and preoperative assessment of risk.

Authors:  T M Sundt; B A Sandok; J P Whisnant
Journal:  Mayo Clin Proc       Date:  1975-06       Impact factor: 7.616

2.  Monitoring techniques for carotid endarterectomy.

Authors:  T M Sundt; F W Sharbrough; J C Trautmann; G A Gronert
Journal:  Clin Neurosurg       Date:  1975

3.  Significance of EEG changes at carotid endarterectomy.

Authors:  W T Blume; G G Ferguson; D K McNeill
Journal:  Stroke       Date:  1986 Sep-Oct       Impact factor: 7.914

Review 4.  The ischemic tolerance of neural tissue and the need for monitoring and selective shunting during carotid endarterectomy.

Authors:  T M Sundt
Journal:  Stroke       Date:  1983 Jan-Feb       Impact factor: 7.914

5.  Cerebral protection during carotid endarterectomy--EEG monitoring as a guide to the use of intraluminal shunts.

Authors:  H Wassmann; G Fischdick; K K Jain
Journal:  Acta Neurochir (Wien)       Date:  1984       Impact factor: 2.216

6.  Correlation of cerebral blood flow and electroencephalographic changes during carotid endarterectomy: with results of surgery and hemodynamics of cerebral ischemia.

Authors:  T M Sundt; F W Sharbrough; D G Piepgras; T P Kearns; J M Messick; W M O'Fallon
Journal:  Mayo Clin Proc       Date:  1981-09       Impact factor: 7.616

7.  Cerebral protection during carotid endarterectomy.

Authors:  J E Thompson
Journal:  Mayo Clin Proc       Date:  1981-09       Impact factor: 7.616

8.  Results of electroencephalographic monitoring during 367 carotid endarterectomies. Use of a dedicated minicomputer.

Authors:  K H Chiappa; S R Burke; R R Young
Journal:  Stroke       Date:  1979 Jul-Aug       Impact factor: 7.914

9.  Risks of carotid endarterectomy. Toronto Cerebrovascular Study Group.

Authors: 
Journal:  Stroke       Date:  1986 Sep-Oct       Impact factor: 7.914

10.  Continuous intraoperative electroencephalographic monitoring in carotid endarterectomy.

Authors:  M Mola; M Collice; A Levati
Journal:  Eur Neurol       Date:  1986       Impact factor: 1.710

View more
  2 in total

1.  Results of microsurgical carotid endarterectomy. A prospective study with transcranial Doppler and EEG monitoring, and elective shunting.

Authors:  H J Steiger; L Schäffler; J Boll; S Liechti
Journal:  Acta Neurochir (Wien)       Date:  1989       Impact factor: 2.216

2.  The carotid endarterectomy: experience with 260 cases and discussion of the indications.

Authors:  R Deruty; C Mottolese; I Pelissou-Guyotat; C Lapras
Journal:  Acta Neurochir (Wien)       Date:  1991       Impact factor: 2.216

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.